Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 19394Generated: October 29, 2026

Diisopropylethylamine → (s)-4-Methyl-2-[4-(2-methyl-benzooxazol-4-yloxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1h-pyrazol-3-yl]-amide

https://huagongshe.com/reaction/19394

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDiisopropylethylamineHCID 81531—
ReactantBenzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphateHCID 151348—
ReactantLithium hydroxide, monohydrateHCID 168937—
ReactantHCID 66894693HCID 66894693—
ReactantHMS5552 HClHCID 66899094—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
SolventTetrahydrofuranHCID 8028—
Product(s)-4-Methyl-2-[4-(2-methyl-benzooxazol-4-yloxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1h-pyrazol-3-yl]-amideHCID 5792012652.2%

Reaction Steps

A solution of (S)-4-methyl-2-[4-(2-methyl-benzooxazol-4-yloxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-pentanoic acid methyl ester (0.570 g, 1.59 mmol) in tetrahydrofuran (10 mL) and water (10 mL) was treated with lithium hydroxide monohydrate (0.134 g 3.12 mmol) and the resulting mixture stirred at room temperature for 1.5 h. The mixture was concentrated in vacuo and the residue treated with acetonitrile, and concentrated in vacuo (repeated 2 additional times). The resulting solid was treated with N,N-dimethylformamide (10 mL) and 1-(3-amino-pyrazol-1-yl)-2-methyl-propan-2-ol (prepared in U.S. Pat. Appl. US2008021032 Example 80, 0.371 g, 2.39 mmol), N,N-diisopropylethylamine (0.820 g, 6.34 mmol) and benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (2.811 g, 6.35 mmol) at 0° C. The reaction mixture was allowed to warm to room temperature and stirred for 18 h. The mixture was concentrated in vacuo, the residue dissolved in ethyl acetate, and the resulting solution was washed with aqueous saturated ammonium chloride solution, brine and dried over sodium sulfate. The mixture was filtered and concentrated in vacuo and the residue purified by ISCO flash column chromatography (Silicycle 40 g, 5% to 100% ethyl acetate/hexanes) which afforded (S)-4-methyl-2-[4-(2-methyl-benzooxazol-4-yloxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide (400 mg, 52%) as a light yellow solid: HR-ES-MS m/z calculated for C25H31N5O5 [M+H]+ 482.2398, observed 482.2398; 1H NMR (300 MHz, DMSO-d6) δ ppm 0.90 (d, J=6.0 Hz, 3H), 0.94 (d, J=6.0 Hz, 3H), 1.05 (br. s., 3H), 1.06 (br. s., 3H), 1.37-1.64 (m, 2H), 1.65-1.85 (m, 1H), 2.62 (s, 3H), 3.89 (s, 2H), 4.24 (d, J=18.1 Hz, 1H), 4.62 (d, J=18.1 Hz, 1H), 4.67 (s, 1H), 4.83 (s, 1H), 4.89 (dd, J=11.0, 3.8 Hz, 1H), 6.45 (s, 1H), 7.29 (d, J=7.8 Hz, 1H), 7.42 (t, J=7.8 Hz, 1H), 7.54 (s, 1H), 7.64 (d, J=7.8 Hz, 1H), 10.80 (s, 1H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07741327B2
Source datasetuspto-grants-2010_06
ORD IDord-33e1447743e64485b559e2497b64b0a9
Source noteuspto-grants-2010_06